Stock Valuation / DOCS
Is Doximity, Inc. (DOCS) Overvalued? Fair Value & 5-Year Target
Doximity, Inc. trades at $30.55 (P/E 36.37). Our reference model estimates a fair value of $35.30 at its recent average P/E of 42.02.
| Current price | $30.55 |
|---|---|
| Current EPS | $0.84 |
| Current P/E | 36.37 |
| Average P/E | 42.02 |
| Fair value (at avg P/E) | $35.30 |
| Upside to fair value | +15.5% |
| Illustrative 5-yr target (25× P/E, 15% growth) | $42.24 |
What drives DOCS's valuation
Changing either assumption moves the target: a higher P/E multiple or faster EPS growth raises fair value, a lower multiple or slower growth lowers it. The interactive dashboard lets you edit both and re-run the model instantly.
About Doximity, Inc.
Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-com
Frequently asked questions
What is DOCS's fair value?
At its recent average P/E of 42.02, Doximity, Inc. (DOCS) has a reference fair value of about $35.30, which is +15.5% versus the current price of $30.55.
Is Doximity, Inc. (DOCS) overvalued or undervalued?
Based on the average-P/E reference model, Doximity, Inc. looks undervalued relative to fair value by roughly +15.5%. This is a model output, not investment advice — change the P/E and growth assumptions in the dashboard for your own view.
What is a 5-year price target for DOCS?
Under an illustrative model of 25× P/E and 15% annual EPS growth, the implied 5-year target is $42.24. Adjust both inputs on the interactive page to match your assumptions.
Open the interactive DOCS valuation dashboard →
Figures are for informational purposes only and are not investment advice. Data as of 2026-10-14.